after the successful introduction of sodium cromoglycate ( scg ) for the treatment of asthma , emphasis was placed on its apparent novel mechanism of action , the inhibition of inflammatory mediator release from mast cells .
C0012694
sodium cromoglycate
C0004096
asthma